Business, energy, technology, markets and global industry news from Business News Today

Korea University College of Medicine

Pharma & Biotech

Can Moderna turn hantavirus urgency into a credible rare-virus vaccine strategy?

Moderna surged on hantavirus hopes. The real test is whether rare-virus urgency can become a viable mRNA vaccine pathway.

Read More